PEG vs PRLD · P/E 18, rev $10.29B vs rev $6.5M
Public Service Enterprise Group Inc (PEG) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the PEG and PRLD stock pages for the full models.
Not investment advice.